The IRCCS Ca’ Granda Ospedale Maggiore Policlinico Foundation, known as Polyclinic of Milan, is a public hospital characterized by a strong interdisciplinary approach and excellent in various areas of care. Given its nature of IRCCS – Institute for Scientific Hospitalization and Care – it carries out, in addition to assistance, biomedical and health research of clinical and translational type, providing a rapid transfer of therapies from the laboratories to the clinic (bench-to-bedside).

The research activity is related to various areas: from neurology to cardiology, from transplants to hematology, as well as to treatment in gynecology, neonatology, geriatrics and rare diseases. The Ministry of Health has recognized the Polyclinic as the first Public IRCCS for the quantity and quality of scientific production.

The Polyclinic of Milan has a reference role within the national and international networks that highlight its distinctive activities. It is indeed a point of reference for pregnancies and complex births and a regional reference center for the treatment of over 260 rare diseases of adults and children. Headquarters of the Northern Italy Transplant Program (NITp), the Polyclinic has allowed more than 32,000 organ transplants since 1972, with success rates exceeding 90% one year after transplantation. It is a university campus with ten health degrees and a master’s degree in Sciences of the health professions of prevention. In the specific field of aging, the Polyclinic has been the promoter since 2008 of the REPOSI register on pharmacological polytherapies, still in progress.

This register that the Polyclinic has created together with the Mario Negri Institute and the Italian Society of Internal Medicine, provides an accurate and updated picture every year of drug prescriptions in the elderly and their appropriateness. Recently AIFA has used this register and thus involved the Polyclinic in its recent OSMED analysis on the use of drugs in the elderly.